News und Analysen
![Xencor to Present Initial Data from the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Xencor to Present Initial Data from the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that initial
![QIAGEN führt portablen Schnelltest ein, der mehr als 30 Proben pro Stunde auf das SARS-CoV-2-Antigen untersuchen kann](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
QIAGEN führt portablen Schnelltest ein, der mehr als 30 Proben pro Stunde auf das SARS-CoV-2-Antigen untersuchen kann
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute Pläne zur Einführung eines portablen Schnelltests bekannt gegeben, der mittels eines kleinen digitalen Testsystems SARS-CoV-2-Antigene
![QIAGEN to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour for SARS-CoV-2 Antigen](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
QIAGEN to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour for SARS-CoV-2 Antigen
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a rapid portable test that can detect SARS-CoV-2 antigens in people with active infections in less than 15 minutes
![Charles River Laboratories to Present at September Investor Conferences](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Charles River Laboratories to Present at September Investor Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:
-
Wells Fargo 2020 Healthcare
![Canopy Growth: Neuer Online-Store, aber bekannte Zahlenschwäche...](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Canopy Growth: Neuer Online-Store, aber bekannte Zahlenschwäche...
Canopy Growth (WKN: A140QA) goes online: Mit dem neuen Online-Store ShopCanopy versucht das Unternehmen aus Smith Falls, Kanada, seine E-Commerce-Aktivitäten zu intensivieren.
Doch bei einem
![Acadia Healthcare to Participate in Baird 2020 Global Healthcare Conference](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Acadia Healthcare to Participate in Baird 2020 Global Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Baird 2020 Global Healthcare Conference, which is being held as a virtual event on September
![Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
Novocure (NASDAQ: NVCR) announced today that William Doyle, the company’s Executive Chairman, and Dr. Uri Weinberg, the company’s Chief Science Officer, will participate in the 2020 Wells Fargo
![Premier Inc. to Present at Upcoming Investor Conferences](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Premier Inc. to Present at Upcoming Investor Conferences
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at two upcoming investor conferences:
-
Baird
![Xencor and MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb® Drug Candidates](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Xencor and MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb® Drug Candidates
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas
![Premier Inc. Earns First Place in AHRQ Predictive Analytics Challenge](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Premier Inc. Earns First Place in AHRQ Predictive Analytics Challenge
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that the Agency for Healthcare Research and Quality (AHRQ) has selected it as a first-place winner in the
![ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
![Evotec: Neue Oxford-Partnerschaft!](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Evotec: Neue Oxford-Partnerschaft!
Dank einer neuen Partnerschaft mit der Oxford Universität wird Evotec (WKN: 566480) zukünftig Zugriff auf Bioproben aus der Biobank "Quality in Organ Donation" erhalten. Darüber informierte das
![LivaNova to Present at the Baird 2020 Global Healthcare Conference](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
LivaNova to Present at the Baird 2020 Global Healthcare Conference
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Baird 2020 Global Healthcare
![Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
Regulatory News:
Vifor Pharma today announced the appointment of Gregory Oakes as EVP, President North America and member of the Vifor Pharma Executive Committee as of September 1, 2020.
![Premier, Inc. Reports Fiscal 2020 Fourth-Quarter and Full-Year Results](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Premier, Inc. Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2020 fourth quarter and full year ended June 30, 2020.
All results presented in this press release reflect
![QIAGEN führt einfach zu bedienenden, digitalen Test zum Nachweis von SARS-CoV-2-Antikörpern nach beantragter FDA-Notfallzulassung auf dem US-Markt ein](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
QIAGEN führt einfach zu bedienenden, digitalen Test zum Nachweis von SARS-CoV-2-Antikörpern nach beantragter FDA-Notfallzulassung auf dem US-Markt ein
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Einführung seines neuen Access Anti-SARS-CoV-2 Total Tests auf dem US-Markt bekannt. Hierbei handelt es sich um einen einfach
![QIAGEN to Launch Easy-to-Use Digital Test in the U.S. for Rapid Detection of SARS-CoV-2 Antibodies Following FDA Emergency Use Authorization](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
QIAGEN to Launch Easy-to-Use Digital Test in the U.S. for Rapid Detection of SARS-CoV-2 Antibodies Following FDA Emergency Use Authorization
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of the new Access Anti-SARS-CoV-2 Total test, an easy-to-use digital test done on a portable device that
![QIAGEN announces new Chairman of Supervisory Board](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
QIAGEN announces new Chairman of Supervisory Board
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced today a transition in the leadership of its Supervisory Board after an extraordinary meeting of the Supervisory Board and
![QIAGEN gibt neuen Aufsichtsratsvorsitzenden bekannt](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
QIAGEN gibt neuen Aufsichtsratsvorsitzenden bekannt
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute im Anschluss an eine außerordentliche Sitzung des Aufsichtsrats und des Vorstands einen Wechsel im Vorsitz des Aufsichtsrats
![QIAGEN bestärkt COVID-19-Forschung mit integrierten Coronavirus-NGS- und Software-Lösungen](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
QIAGEN bestärkt COVID-19-Forschung mit integrierten Coronavirus-NGS- und Software-Lösungen
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat das innovative QIAseq-SARS-CoV-2-Primer-Panel für Next-Generation-Sequencing (NGS) des Genoms des neuartigen Coronavirus sowie integrierte
![QIAGEN Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
QIAGEN Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with integrated
![Premier Inc. Working with AstraZeneca to Reduce Hospitalizations of Patients with Hyperkalemia](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Premier Inc. Working with AstraZeneca to Reduce Hospitalizations of Patients with Hyperkalemia
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today it has reached a significant milestone in its partnership with AstraZeneca, a global, science-led
![QIAGEN wird erfolgreiche Wachstumsstrategie mit Fokus auf Umsetzung und mehr Wertschöpfung weiterverfolgen, nachdem das freiwillige öffentliche Übernahmeangebot von Thermo Fisher gescheitert ist](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
QIAGEN wird erfolgreiche Wachstumsstrategie mit Fokus auf Umsetzung und mehr Wertschöpfung weiterverfolgen, nachdem das freiwillige öffentliche Übernahmeangebot von Thermo Fisher gescheitert ist
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, seine erfolgreiche Wachstumsstrategie mit dem Ziel einer deutlichen Wertsteigerung für Aktionäre und andere
![QIAGEN to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation After Voluntary Public Takeover Offer Falls Short](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
QIAGEN to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation After Voluntary Public Takeover Offer Falls Short
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will continue to execute its successful growth strategy aiming to create significant value for shareholders and other
![Novocure Announces Expansion of Its Executive Leadership Team](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Novocure Announces Expansion of Its Executive Leadership Team
Novocure (NASDAQ:NVCR) today announced an expansion of its Executive Leadership Team, effective Sept. 1, 2020, intended to further solidify executive leadership in preparation for an anticipated